Page last updated: 2024-08-23

mezlocillin and isepamicin

mezlocillin has been researched along with isepamicin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Barrett, MS; Erwin, ME; Johnson, DM; Jones, RN	1

Other Studies

2 other study(ies) available for mezlocillin and isepamicin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:5 Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas	1991

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli

Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:5

Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas

1991